Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design

New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex c...

Full description

Saved in:
Bibliographic Details
Published in:Cell stem cell 2017-01, Vol.20 (1), p.13-17
Main Authors: Lipsitz, Yonatan Y., Bedford, Patrick, Davies, Anthony H., Timmins, Nicholas E., Zandstra, Peter W.
Format: Article
Language:English
Subjects:
Artificial Cells - cytology
Cell Engineering
Cell- and Tissue-Based Therapy - standards
Humans
Social Control, Formal
Translational Medical Research
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253
cites cdi_FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253
container_end_page 17
container_issue 1
container_start_page 13
container_title Cell stem cell
container_volume 20
creator Lipsitz, Yonatan Y.
Bedford, Patrick
Davies, Anthony H.
Timmins, Nicholas E.
Zandstra, Peter W.
description New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics. New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.
doi_str_mv 10.1016/j.stem.2016.12.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1856593587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1934590916304593</els_id><sourcerecordid>1856593587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253</originalsourceid><addsrcrecordid>eNp9kE-P0zAQxS0EYv-wX4AD8pFLwtipY1viUpVlQVqEEMtxZTnOuHHVJsV2Vuq3x1EXjpzmafTe08yPkLcMagas_bCrU8ZDzYuuGa8BmhfkkikpKi2lfFm0blaV0KAvyFVKOwAhGcjX5IIraFkj4JI8rt0Q8CmMW3rrfXABx0y_2XH21uU5Lns79vTHbPchn-g6pTna0SHNQ5zm7UB_nsY8YA6ObnC_pw8DRns80U-YwnZ8Q155u0948zyvya_Ptw-bL9X997uvm_V95VYAufI991zIlW8BGw--A9ZbyZngvhNC965rVdcx1Sot_Eqjb6TCziupoWMl2VyT9-feY5x-z5iyOYTkyj12xGlOhinRCt0IJYuVn60uTilF9OYYw8HGk2FgFqxmZxasZsFqGDcFawm9e-6fuwP2_yJ_ORbDx7MBy5dPAaNJC0qHfYjosumn8L_-PzR7ih0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1856593587</pqid></control><display><type>article</type><title>Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Lipsitz, Yonatan Y. ; Bedford, Patrick ; Davies, Anthony H. ; Timmins, Nicholas E. ; Zandstra, Peter W.</creator><creatorcontrib>Lipsitz, Yonatan Y. ; Bedford, Patrick ; Davies, Anthony H. ; Timmins, Nicholas E. ; Zandstra, Peter W.</creatorcontrib><description>New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics. New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.</description><identifier>ISSN: 1934-5909</identifier><identifier>EISSN: 1875-9777</identifier><identifier>DOI: 10.1016/j.stem.2016.12.003</identifier><identifier>PMID: 28061350</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Artificial Cells - cytology ; Cell Engineering ; Cell- and Tissue-Based Therapy - standards ; Humans ; Social Control, Formal ; Translational Medical Research</subject><ispartof>Cell stem cell, 2017-01, Vol.20 (1), p.13-17</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253</citedby><cites>FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28061350$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lipsitz, Yonatan Y.</creatorcontrib><creatorcontrib>Bedford, Patrick</creatorcontrib><creatorcontrib>Davies, Anthony H.</creatorcontrib><creatorcontrib>Timmins, Nicholas E.</creatorcontrib><creatorcontrib>Zandstra, Peter W.</creatorcontrib><title>Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design</title><title>Cell stem cell</title><addtitle>Cell Stem Cell</addtitle><description>New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics. New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.</description><subject>Artificial Cells - cytology</subject><subject>Cell Engineering</subject><subject>Cell- and Tissue-Based Therapy - standards</subject><subject>Humans</subject><subject>Social Control, Formal</subject><subject>Translational Medical Research</subject><issn>1934-5909</issn><issn>1875-9777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE-P0zAQxS0EYv-wX4AD8pFLwtipY1viUpVlQVqEEMtxZTnOuHHVJsV2Vuq3x1EXjpzmafTe08yPkLcMagas_bCrU8ZDzYuuGa8BmhfkkikpKi2lfFm0blaV0KAvyFVKOwAhGcjX5IIraFkj4JI8rt0Q8CmMW3rrfXABx0y_2XH21uU5Lns79vTHbPchn-g6pTna0SHNQ5zm7UB_nsY8YA6ObnC_pw8DRns80U-YwnZ8Q155u0948zyvya_Ptw-bL9X997uvm_V95VYAufI991zIlW8BGw--A9ZbyZngvhNC965rVdcx1Sot_Eqjb6TCziupoWMl2VyT9-feY5x-z5iyOYTkyj12xGlOhinRCt0IJYuVn60uTilF9OYYw8HGk2FgFqxmZxasZsFqGDcFawm9e-6fuwP2_yJ_ORbDx7MBy5dPAaNJC0qHfYjosumn8L_-PzR7ih0</recordid><startdate>20170105</startdate><enddate>20170105</enddate><creator>Lipsitz, Yonatan Y.</creator><creator>Bedford, Patrick</creator><creator>Davies, Anthony H.</creator><creator>Timmins, Nicholas E.</creator><creator>Zandstra, Peter W.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170105</creationdate><title>Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design</title><author>Lipsitz, Yonatan Y. ; Bedford, Patrick ; Davies, Anthony H. ; Timmins, Nicholas E. ; Zandstra, Peter W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Artificial Cells - cytology</topic><topic>Cell Engineering</topic><topic>Cell- and Tissue-Based Therapy - standards</topic><topic>Humans</topic><topic>Social Control, Formal</topic><topic>Translational Medical Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lipsitz, Yonatan Y.</creatorcontrib><creatorcontrib>Bedford, Patrick</creatorcontrib><creatorcontrib>Davies, Anthony H.</creatorcontrib><creatorcontrib>Timmins, Nicholas E.</creatorcontrib><creatorcontrib>Zandstra, Peter W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell stem cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lipsitz, Yonatan Y.</au><au>Bedford, Patrick</au><au>Davies, Anthony H.</au><au>Timmins, Nicholas E.</au><au>Zandstra, Peter W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design</atitle><jtitle>Cell stem cell</jtitle><addtitle>Cell Stem Cell</addtitle><date>2017-01-05</date><risdate>2017</risdate><volume>20</volume><issue>1</issue><spage>13</spage><epage>17</epage><pages>13-17</pages><issn>1934-5909</issn><eissn>1875-9777</eissn><abstract>New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics. New methods to manipulate gene and cell state can be used to engineer cell functionality, simplify quality assessment, and enhance manufacturability. These strategies could help overcome unresolved cell therapy manufacturing challenges and complement frameworks to design quality into these complex cellular systems, ultimately increasing patient access to living therapeutics.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28061350</pmid><doi>10.1016/j.stem.2016.12.003</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1934-5909
ispartof Cell stem cell, 2017-01, Vol.20 (1), p.13-17
issn 1934-5909
1875-9777
language eng
recordid cdi_proquest_miscellaneous_1856593587
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Artificial Cells - cytology
Cell Engineering
Cell- and Tissue-Based Therapy - standards
Humans
Social Control, Formal
Translational Medical Research
title Achieving Efficient Manufacturing and Quality Assurance through Synthetic Cell Therapy Design
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A59%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Achieving%20Efficient%20Manufacturing%20and%20Quality%20Assurance%20through%20Synthetic%20Cell%20Therapy%20Design&rft.jtitle=Cell%20stem%20cell&rft.au=Lipsitz,%20Yonatan%20Y.&rft.date=2017-01-05&rft.volume=20&rft.issue=1&rft.spage=13&rft.epage=17&rft.pages=13-17&rft.issn=1934-5909&rft.eissn=1875-9777&rft_id=info:doi/10.1016/j.stem.2016.12.003&rft_dat=%3Cproquest_cross%3E1856593587%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c400t-fd2f2574f60e3f0fb01da72152fb559dcb68bb186895f49ef378ebf8790b1f253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1856593587&rft_id=info:pmid/28061350&rfr_iscdi=true